Latest Uk Market News

Nick Scali Limited posted a 31% jump in net profit after tax to $75.7 million for FY26, driven by margin gains and UK sales recovery, and announced a fully franked final dividend of 39 cents per share.

Memphasys secures exclusive Felix™ commercialisation agreement in Poland, marking its third European market entry with a two-year contract valued at approximately A$350,000.

Credit Corp delivered a 12% profit rise to a record $105.5 million in FY2026, powered by a 57% surge in US debt buying earnings and a strategic entry into UK consumer lending.

Aspermont Limited reported a 25% year-on-year revenue increase to A$4.5 million in Q3 FY26, achieving normalised EBITDA breakeven for the first time and marking its 40th consecutive quarter of subscription growth. The company’s Data & Intelligence platform advances with key contracts underway and non-subscription revenues surging.

PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.

BLS Pharmaceuticals capped FY26 with record revenue and EBITDA, boosted by international expansion and major contracts, setting the stage for further growth in FY27.

Credit Clear Limited has posted a 28% revenue increase to $60 million and a 41% jump in underlying EBITDA to $10.4 million for FY26, beating guidance and driven by organic growth and recent acquisitions in Europe and debt collection.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

Rua Bioscience has secured its largest export contract, committing to supply New Zealand-grown medical cannabis flower to a major UK distributor, projecting over NZ$10 million in revenue across two years.

Love Group Global Ltd (ASX:LVE) reported a record net operating cash flow of $974k for FY26, a 49% increase despite a 13% decline in customer cash receipts. The company plans to grow its matchmaking business in Asia and test expansion into the US and UK.

Zoono Group has reported a 94% jump in quarterly cash receipts to NZ$975K, turning cash flow positive amid expanding commercial rollouts of its shelf-life extension technology across multiple continents.

PEXA faces a proposed 20% cut in regulated ELNO service fees, risking a $70 million revenue reduction over a year. The company urges a phased approach to mitigate business impact as IPART opens public consultation.